CIM
ABMD

Calvert Investment Management’s Abiomed Inc ABMD Stock Holding History

Calvert Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,587
Closed -$292K – 664
2016
Q4 		$292K Buy
2,587
+32
+1% +$3.71K 0.01% 675
2016
Q3 		$329K Buy
2,555
+313
+14% +$37.5K 0.01% 628
2016
Q2 		$245K Buy
2,242
+20
+0.9% +$1.99K 0.01% 676
2016
Q1 		$211K Buy
+2,222
New +$188K 0.01% 690

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Calvert Investment Management's ABMD Position: Q1 2017 in Review

Calvert Investment Management sold out of Abiomed Inc (ABMD) in Q1 2017, closing a stake of 2,587 shares — an estimated $292K sold.

Calvert Investment Management first reported a position in ABMD in Q1 2016 and held it in 4 quarters. The position peaked at $329K in Q3 2016. 287 funds tracked by Wall St. Rank hold ABMD as of Q1 2017.

  • Calvert Investment Management reported no remaining Abiomed Inc position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 2,587 Abiomed Inc shares in Q1 2017, an estimated $292K.
  • Calvert Investment Management first reported a position in Abiomed Inc in Q1 2016 and held it in 4 quarters.
  • Calvert Investment Management's Abiomed Inc position peaked at $329K in Q3 2016.
  • 287 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.